BioSpace News Archive

Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company.

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body’s immune system to fight cancer, announced that the VA North Texas Health Care System and its non-profit affiliate, the Dallas VA Research Corporation, have joined Anixa’s ongoing prostate cancer Cchek™ study.

Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, announced positive topline results from its pilot effectiveness study of KIND-016, a fully caninized, high-affinity monoclonal antibody targeting interleukin-31, for the treatment of atopic dermatitis in dogs.

Genomic Health, Inc. reported financial results and business progress for the quarter ended June 30, 2019.

RSV Test Represents Expansion of FDA Cleared, CLIA-Waived and CE Marked PCR Point-of-care Testing Portfolio

The notes will be senior unsecured obligations of Select and will be guaranteed by certain of Select’s subsidiaries.

With the best U.S. economy in 60 years, Mitch Gould, founder and CEO of NPI, said snack and beverage companies are entering the consumer market at the right time.

NEC Corporation announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer.

Laboratoire Synbionyme, a Paris-based skincare company, urges everyone to use National Ultraviolet Safety Month in July as the kick-starter to protect their skin.

World Pharmatech developed XtraLast® to help the 12 million men in the U.S. with some form of erectile dysfunction.